Showing results (501-510 of 538) with videos related to

Sort By:
Pageof 54
The New England Journal of Medicine|November 25, 2017
Fremanezumab for the Preventive Treatment of Chronic MigraineStephen D Silberstein, David W Dodick, Marcelo E Bigal, et al.
JAMA|May 26, 2018
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical TrialDavid W Dodick, Stephen D Silberstein, Marcelo E Bigal, et al.
Headache|September 6, 2016
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 StudyStephen D Silberstein, Laszlo L Mechtler, David B Kudrow, et al.
Cephalalgia : an International Journal of Headache|October 27, 2010
Randomized, controlled trial of telcagepant over four migraine attacksAndrew P Ho, Carl Gh Dahlöf, Stephen D Silberstein, et al.
The Lancet. Neurology|October 4, 2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b studyMarcelo E Bigal, David W Dodick, Alan M Rapoport, et al.
Headache|June 14, 2023
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysisStewart J Tepper, Richard B Lipton, Stephen D Silberstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2004
Heregulin ameliorates the dystrophic phenotype in mdx miceThomas O B Krag, Sasha Bogdanovich, Claus J Jensen, et al.
Cephalalgia : an International Journal of Headache|June 9, 2018
Vancouver Declaration on Global Headache Patient Advocacy 2018David Dodick, Lars Edvinsson, Tomohiko Makino, et al.
The Lancet. Neurology|March 9, 2010
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trialRichard B Lipton, David W Dodick, Stephen D Silberstein, et al.
Cephalalgia : an International Journal of Headache|September 15, 2021
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trialTodd J Schwedt, Richard B Lipton, Jessica Ailani, et al.
Pageof 54